Measures 24?hour urinary oxalate excretion to assess the risk of kidney stone formation.

Simultaneously screens for six common respiratory pathogens to diagnose infections.

Analyzes genetic variants to predict patient response to clopidogrel therapy.

Detects the JAK2 V617F mutation associated with myeloproliferative disorders using DNA analysis.

Analyzes BRCA1 and BRCA2 mutations to assess genetic risk for breast and ovarian cancers.

Measures serum myoglobin to detect muscle injury and assess myocardial infarction risk.

Determines calcium excretion in urine to evaluate metabolic status and kidney function.

Calculates the Homeostatic Model Assessment for Insulin Resistance to evaluate metabolic health.

Measures interleukin-6 levels as a marker of inflammation and immune activation.

Assesses urine creatinine levels to help evaluate kidney function and muscle mass.